Abstract
In hyperbaric oxygen therapy (HBOT), the subject is placed in a chamber containing 100% oxygen gas at a pressure of more than one atmosphere absolute. This treatment is used to hasten tissue recovery and improve its physiological aspects, by providing an increased supply of oxygen to the damaged tissue. In this review, we discuss the consequences of hypoxia, as well as the molecular and physiological processes that occur in subjects exposed to HBOT. We discuss the efficacy of HBOT in treating neurological conditions and neurodevelopmental disorders in both humans and animal models. We summarize by discussing the challenges in this field, and explore future directions that will allow the scientific community to better understand the molecular aspects and applications of HBOT for a wide variety of neurological conditions.
| Original language | English |
|---|---|
| Article number | 1247 |
| Pages (from-to) | 1-17 |
| Number of pages | 17 |
| Journal | Biomolecules |
| Volume | 10 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Angiogenesis
- Autistic spectrum disorder
- Cerebral palsy
- Hyperbaric oxygen therapy
- Hypoxia
- Mitochondria
- Neurodevelopmental disorders
- Neurological conditions
- Reactive oxygen stress
- Traumatic brain injury
- White matter
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Biology
Fingerprint
Dive into the research topics of 'Molecular and therapeutic aspects of hyperbaric oxygen therapy in neurological conditions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver